Hepatitis Monthly

Published by: Kowsar

Diverse Genotypes of Hepatitis C Virus in Voluntary Blood Donors in Shanghai, China

Hongyan Wu 1 , 2 , Yu Wang 3 , Ping Gong 4 , Xiangyuan Huang 3 , Xichang Zhao 1 , 2 , Weiping Zhu 1 , 2 , Qingwu Jiang 3 and Yihan Lu 2 , 3 , *
Authors Information
1 Pudong New Area Center for Disease Control and Prevention, Shanghai, China
2 Fudan University Pudong Institute of Preventive Medicine, Shanghai, China
3 Key Laboratory of Public Health Safety (Ministry of Education), Fudan University School of Public Health, Shanghai, China
4 Pudong New Area Blood Center, Shanghai, China
Article information
  • Hepatitis Monthly: June 2017, 17 (6); e13160
  • Published Online: June 17, 2017
  • Article Type: Research Article
  • Received: May 13, 2017
  • Accepted: June 8, 2017
  • DOI: 10.5812/hepatmon.13160

To Cite: Wu H, Wang Y, Gong P, Huang X, Zhao X, et al. Diverse Genotypes of Hepatitis C Virus in Voluntary Blood Donors in Shanghai, China, Hepat Mon. 2017 ;17(6):e13160. doi: 10.5812/hepatmon.13160.

Abstract
Copyright: Copyright © 2017, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
1. Background
2. Methods
3. Results
4. Discussion
Footnotes
References
  • 1. Prati D. Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review. J Hepatol. 2006; 45(4): 607-16[DOI][PubMed]
  • 2. Velati C, Romano L, Fomiatti L, Baruffi L, Zanetti AR, Simti Research Group . Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Transfusion. 2008; 48(10): 2205-13[DOI][PubMed]
  • 3. Zou S, Musavi F, Notari EP, Stramer SL, Dodd RY. Prevalence, incidence, and residual risk of major blood-borne infections among apheresis collections to the American Red Cross Blood Services, 2004 through 2008. Transfusion. 2010; 50(7): 1487-94[DOI][PubMed]
  • 4. Kim MJ, Park Q, Min HK, Kim HO. Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010. BMC Infect Dis. 2012; 12: 160[DOI][PubMed]
  • 5. Gao X, Cui Q, Shi X, Su J, Peng Z, Chen X, et al. Prevalence and trend of hepatitis C virus infection among blood donors in Chinese mainland: a systematic review and meta-analysis. BMC Infect Dis. 2011; 11: 88[DOI][PubMed]
  • 6. Zheng X, Ding W, Li G, Wu Y, Wu D, Zhu H, et al. Seroprevalence of transfusion-transmissible infectious agents among volunteer blood donors between 2006 and 2012 in Zhejiang, China. Blood Transfus. 2015; 13(3): 401-10[DOI][PubMed]
  • 7. Ji ZH, Li CY, Lv YG, Cao W, Chen YZ, Chen XP, et al. The prevalence and trends of transfusion-transmissible infectious pathogens among first-time, voluntary blood donors in Xi'an, China between 1999 and 2009. Int J Infect Dis. 2013; 17(4)-62[DOI][PubMed]
  • 8. Song Y, Bian Y, Petzold M, Ung CO. Prevalence and trend of major transfusion-transmissible infections among blood donors in Western China, 2005 through 2010. PLoS One. 2014; 9(4)[DOI][PubMed]
  • 9. Wang J, Liu J, Huang Y, Wright DJ, Li J, Zhou Z, et al. The persistence of hepatitis C virus transmission risk in China despite serologic screening of blood donations. Transfusion. 2013; 53(10 Pt 2): 2489-97[DOI][PubMed]
  • 10. Kafi-abad SA, Rezvan H, Abolghasemi H, Talebian A. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion. 2009; 49(10): 2214-20[DOI][PubMed]
  • 11. de Almeida-Neto C, Sabino EC, Liu J, Blatyta PF, Mendrone-Junior A, Salles NA, et al. Prevalence of serologic markers for hepatitis B and C viruses in Brazilian blood donors and incidence and residual risk of transfusion transmission of hepatitis C virus. Transfusion. 2013; 53(4): 827-34[DOI][PubMed]
  • 12. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology. 2005; 42(4): 962-73[DOI][PubMed]
  • 13. Murphy DG, Sablon E, Chamberland J, Fournier E, Dandavino R, Tremblay CL. Hepatitis C virus genotype 7, a new genotype originating from central Africa. J Clin Microbiol. 2015; 53(3): 967-72[DOI][PubMed]
  • 14. Lu L, Wang M, Xia W, Tian L, Xu R, Li C, et al. Migration patterns of hepatitis C virus in China characterized for five major subtypes based on samples from 411 volunteer blood donors from 17 provinces and municipalities. J Virol. 2014; 88(13): 7120-9[DOI][PubMed]
  • 15. Sarrazin C. The importance of resistance to direct antiviral drugs in HCV infection in clinical practice. J Hepatol. 2016; 64(2): 486-504[DOI][PubMed]
  • 16. Pybus OG, Barnes E, Taggart R, Lemey P, Markov PV, Rasachak B, et al. Genetic history of hepatitis C virus in East Asia. J Virol. 2009; 83(2): 1071-82[DOI][PubMed]
  • 17. Nei M, Kumar S. Molecular evolution and phylogenetics. 2000;
  • 18. China, UAE make big progress in ensuring safe blood donation. 2008;
  • 19. Chen YS, Li L, Cui FQ, Xing WG, Wang L, Jia ZY, et al. [A sero-epidemiological study on hepatitis C in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2011; 32(9): 888-91[PubMed]
  • 20. El Ekiaby M, Moftah F, Goubran H, van Drimmelen H, LaPerche S, Kleinman S, et al. Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios. Transfusion. 2015; 55(6): 1186-94[DOI][PubMed]
  • 21. Dong J, Wu Y, Zhu H, Li G, Lv M, Wu D, et al. A pilot study on screening blood donors with individual-donation nucleic acid testing in China. Blood Transfus. 2014; 12(2): 172-9[DOI][PubMed]
  • 22. Zhang K, Wang L, Sun Y, Zhang R, Lin G, Xie J, et al. Improving the safety of blood transfusion by using a combination of two screening assays for hepatitis C virus. Transfus Med. 2014; 24(5): 297-304[DOI][PubMed]
  • 23. Choudhury N, Tulsiani S, Desai P, Shah R, Mathur A, Harimoorthy V. Serial follow-up of repeat voluntary blood donors reactive for anti-HCV ELISA. Asian J Transfus Sci. 2011; 5(1): 26-31[DOI][PubMed]
  • 24. Garten RJ, Zhang J, Lai S, Liu W, Chen J, Yu XF. Coinfection with HIV and hepatitis C virus among injection drug users in southern China. Clin Infect Dis. 2005; 41 Suppl 1-24[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader